Management of the effects of exposure to tear gas

BMJ (Online)

Volumn 338, Issue 7710, 2009, Pages 1554-1558

  Carron, Pierre Nicolas ^a   Yersin, Bertrand ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLOROBENZYLIDENEMALONONITRILE; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CAPSAICIN DERIVATIVE; CORTICOSTEROID; DIBENZOXAZEPINE DERIVATIVE; IPRATROPIUM BROMIDE; NONANOIC ACID DERIVATIVE; OLEORESIN; PHENACYL CHLORIDE; TEAR GAS; UNCLASSIFIED DRUG;

BIOETHICS; BRAIN HEMORRHAGE; BRONCHOSPASM; BURN; CHEMICAL STRUCTURE; CLINICAL FEATURE; CORNEA EROSION; ERYTHEMA; EYE LAVAGE; FACE EDEMA; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; HYPOXEMIA; HYSTERIA; INTRAOCULAR HEMORRHAGE; IRRITANT DERMATITIS; KERATITIS; LIVER TOXICITY; LUNG EDEMA; PATIENT CARE; PATIENT IDENTIFICATION; POPULATION EXPOSURE; PRIORITY JOURNAL; REVIEW; SKIN DEFECT; TOXICITY;

DECONTAMINATION; EMERGENCY TREATMENT; ENVIRONMENTAL EXPOSURE; ETHICS, MEDICAL; EYE DISEASES; GAS POISONING; HUMANS; RESPIRATORY TRACT DISEASES; RIOTS; SKIN DISEASES; TEAR GASES;

EID: 67650021298     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b2283     Document Type: Review

References (30)

1. Martin C, Newcombe EA. Emergency care during the 1999 World Trade Organization meeting in Seattle. J Emerg Nurs 2001;27:478-80.
2. Weir E. The health impact of crowd-control agents. Can Med Ass J 2001;164:1889-90.
3. Wheeler H, MacLehose R, Euripidou E, Murray V. Surveillance into crowd control agents. Lancet 1998;352:991-2.
4. Olajos E, Salem H. Riot control agents: pharmacology, toxicology, biochemistry and chemistry. J Appl Toxicol 2001;21:355-91.
5. Sanford J. Medical aspects of riot control (harassing) agents. Annu Rev Med 1976;27:421-9.
6. OMEGA Foundation. Crowd control technologies (an appraisal of technologies for political control). European Parliament. 2000. (www.europarl.europa.eu/stoa/publications/studies/ 19991401a-en.pdf)
7. Smith J, Greaves I. The use of chemical incapacitant sprays: a review. J Trauma 2002;52:595-600.
8. Recer G, Johnson T, Gleason A. An evaluation of the relative potential public health concern for the self-defense spray active ingredients oleoresin capsicum, o-chlorobenzylidene malononitrile, and 2-chloroacetophenone. Reg Toxicol Pharma 2002;36:1-11.
9. McMahon S, Wood J. Increasingly irritable and close to tears: TRPA1 in inflammatory pain. Cell 2006;124:1123-5.
10. Kluchinsky T, Savage P, Fitz R, Smith P. Liberation of hydrogen cyanide and hydrogen chloride during high-temperature dispersion of CS riot control agent. AIHA J 2002;63:493-6.
11. Euripidou E, MacLehose R, Fletcher A. An investigation into the short term and medium term health impacts of personal incapacitants sprays. A follow up of patients reported to the National Poisons Information Service (London). Emerg Med J 2004;21:548-52.
12. Anderson PJ, Lau GS, Taylor WR, Critchley JA. Acute effects of the potent lacrimator o-chlorobenzylidene malononitrile (CS) tear gas. Hum Exp Toxicol 1996;15:461-5.
13. Thorburn KM. Injuries after use of lacrymatory agent cloroacetophenone in a confined space. Arch Environ Health 1982;37:182-6.
14. Morrone A, Sacerdoti G, Franco R, Corretti R, Fazio M. Tear gas dermatitis. Clin Exp Dermatol 2005;230:435-6.
15. Zekri A, King W, Yeung R, Taylor W. Acute mass burns caused by ochlorobenzylidene malononitrile (CS) tear gas. Burns 1995;21:586-9.
16. Watson K, Rycroft R. Unintended cutaneous reactions to CS spray. Contact Dermatitis 2005;53:9-13.
17. Vilke G, Chan TC. Less lethal technology:medical issues. Policing: an International Journal of Police Strategies and Management 2007;30:341-57.
18. Vaca F, Myers JH, Langdorf M. Delayed pulmonary oedema and bronchospams after accidental lacrimator exposure. Am J Emerg Med 1996;14:402-5.
19. Hill AR, Silverberg N, Mayorga D, Baldwin H. Medical hazards of the tear gas CS: a case of persistent, multisystem, hypersensitivity reaction and review of the literature. Medicine (Baltimore) 2000;79:234-40.
20. Karagama Y, Newton J, Newbegin C. Short-term and long-term physical effects of exposure to CS spray. J R Soc Med 2003;96:172-4.
21. Williams S, Clark R, Dunford J. Contact dermatitis associated with capsaicin: Hunan hand syndrom. Ann Emerg Med 1994;25:713-5.
22. Watson W, Stremel K, Westdorp EJ. Oleoresin capsicum (cap-stun) toxicity from aerosol exposure. Ann Pharmacother 1996;30:733-5.
23. Horton D, Burgess P, Rossiter S, Kaye W. Secondary contamination of emergency department personnel from o-chlorobenzylidene malononitrile exposure. Ann Emerg Med 2005;45:655-8.
24. Horton D, Berkowitz Z, Kaye W. Secondary contamination of ED personnel from hazardous materials events 1995-2001. Am J Emerg Med 2003;21:199-204.
25. Kales S, Christiani D. Acute chemical emergencies. N Engl JMed 2004;350:800-8.
26. Blaho K, Stark M. Is CS spray dangerous? BMJ 2000;321:46.
27. Winslow JE, Hill KD, Bozenman WP. Determination of optimal methods of decontamination after tear gas and pepper spray exposure. Ann Emerg Med 2006;48:S51.
28. Viala B, Blomet J, Mathieu L, Hall A. Prevention of CS (tear gas) eye and skin effects and active decontamination with Diphoterine: preliminary studies in five French gendarmes. J Emerg Med 2005;29:5-8.
29. Solomon I, Kochba L, Eizenkraft E, Maharshak N. Report of accidental CSingestionamongsevenpatients in central Israeland review of the current literature. Arch Toxicol 2003;77:601-4.
30. "Safety" of chemical batons. Lancet 1998;352:159.